Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)
Top Cited Papers
- 1 May 2011
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 377 (9778) , 1663-1672
- https://doi.org/10.1016/s0140-6736(11)60355-3
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Biomarkers of splenic function in infants with sickle cell anemia: baseline data from the BABY HUG TrialBlood, 2011
- How I use hydroxyurea to treat young patients with sickle cell anemiaBlood, 2010
- The risks and benefits of long‐term use of hydroxyurea in sickle cell anemia: A 17.5 year follow‐upAmerican Journal of Hematology, 2010
- The pediatric hydroxyurea phase III clinical trial (BABY HUG): Challenges of study designPediatric Blood & Cancer, 2009
- Urine concentrating ability in infants with sickle cell disease: Baseline data from the phase III trial of hydroxyurea (BABY HUG)Pediatric Blood & Cancer, 2009
- A pilot study of hydroxyurea to prevent chronic organ damage in young children with sickle cell anemiaPediatric Blood & Cancer, 2008
- Prediction of adverse outcomes in children with sickle cell anemia: a study of the Dallas Newborn CohortBlood, 2008
- A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemiaThe Journal of Pediatrics, 2001
- Effect of Hydroxyurea on the Frequency of Painful Crises in Sickle Cell AnemiaNew England Journal of Medicine, 1995
- Cox's Regression Model for Counting Processes: A Large Sample StudyThe Annals of Statistics, 1982